Habits

Health Screenings in Your 60s

In your 60s, bone and aortic screening follow different eligibility rules, while several tests begin to end. Here's what starts and stops.

7 min read · Longevity365 Editorial

Your 60s are the decade when the screening list starts to change direction. Humanic Blue’s guide tracks tests that arrive around 65 alongside those that reach their end dates. Knowing both halves helps avoid missed tests and unnecessary ones.

The US Preventive Services Task Force (USPSTF) recommends bone-density screening for women from 65 and a one-time ultrasound for some adults ages 65 to 75 to check for an abdominal aortic aneurysm—a bulge in the main artery through the abdomen. Its recommendation covers people in its “men” category who have ever smoked; those categories reflect sex at birth rather than gender identity. The eligibility details appear below.

Other tests continue or become more selective. Cervical screening can stop after 65 only with adequate prior screening and no high-risk condition. Evidence is insufficient for routine anxiety screening from 65, which does not mean ignoring symptoms. Colorectal, breast and eligible lung screening continue on separate schedules. These changes concern disease prevention and function; none guarantees living longer and better.

Key Takeaways

  • The USPSTF recommends bone-density screening for women 65 and older and one-time aortic screening for eligible ever-smokers 65 to 75 under its sex-at-birth categories.
  • Cervical screening stops after 65 for people with adequate prior screening who aren’t at high risk.
  • Colorectal (to 75), breast (to 74) and lung (to 80, if eligible) screening continue.
  • The USPSTF recommends exercise to prevent falls from 65 for adults living in the community who are at increased risk.
  • Evidence that a screening test reduces deaths from a specific disease is different from evidence that it extends overall life.
Hands hold a clipboard and pen in front of a white coat and stethoscope.

Which screenings start at 65?

Bone density for women. The USPSTF’s 2025 recommendation supports screening women 65 and older, with earlier screening for postmenopausal women at increased risk. Evidence for screening men is insufficient. The recommendation does not apply to people with a previous fracture from minor trauma or osteoporosis caused by another condition or medication, who need diagnostic or condition-specific care. The test is covered in DEXA Scans Explained.

Aortic aneurysm screening. The USPSTF recommends one-time ultrasound for men 65 to 75 who have ever smoked, commonly defined as at least 100 lifetime cigarettes. The task force says these sex categories reflect sex at birth rather than gender identity, and a clinician can assess which guidance applies. For men who never smoked, it advises selective rather than routine screening. It recommends against routine screening in women who never smoked and have no family history, and finds evidence insufficient for women 65 to 75 who have smoked or have a family history.

Fall prevention. From 65, the USPSTF recommends exercise interventions for adults at increased risk of falls who live at home or elsewhere in the community rather than a care institution. It does not recommend one universal screening test or exercise program; risk can be assessed from falls, mobility and clinical factors. Balance programs are covered in Improve Balance After 60.

What ends in the 60s

Cervical screening. The current final USPSTF recommendation advises against screening after 65 only for people with adequate prior screening who are not otherwise at high risk. If records are incomplete or there is a history of high-grade precancer, cervical cancer, immune suppression or exposure before birth to the medication diethylstilbestrol (DES), ask before stopping. An update is underway, but it has not replaced the current final recommendation.

Anxiety screening. The USPSTF recommends screening adults younger than 65 but finds the evidence insufficient at 65 and older because accuracy and outcome evidence in older adults are inadequate. That is not a recommendation against evaluation: anxiety symptoms still deserve attention. Depression screening has no equivalent upper-age cutoff.

HIV screening. Routine screening is recommended through age 65; it continues beyond that for people at risk.

Approaching end dates. Under current final USPSTF guidance, prostate-specific antigen (PSA) blood testing is an individual decision for men 55 to 69 and is not recommended routinely from 70; an update is in progress. The USPSTF diabetes recommendation covers adults 35 to 70 with overweight or obesity, while the American Diabetes Association’s (ADA) 2026 standard starts everyone else by 35 and does not impose the same upper cutoff. See Prostate Health as You Age.

Which qualifications determine whether a screening stopping age applies?

A blue upper-arm blood-pressure cuff with a white arm diagram lies on a white surface.

Which screenings continue through your 60s?

These carry over from your 50s, as covered in Health Screenings in Your 50s:

  • Colorectal cancer screening through 75.
  • Mammograms every two years through 74.
  • Lung cancer CT yearly through 80 for people with at least a 20 pack-year history (a pack a day for 20 years, or an equivalent total) who smoke now or quit within 15 years, stopping when eligibility or the ability and willingness to undergo treatment intended to cure the cancer changes.
  • Blood pressure and cardiovascular risk review. The USPSTF recommendation on cholesterol-lowering statin medication covers eligible adults ages 40–75. The American College of Cardiology and American Heart Association (ACC/AHA) use a different framework in their 2026 blood-fat guideline: PREVENT risk calculators for people without established cardiovascular disease, with ages depending on the prediction period.
  • Depression screening.
  • Hepatitis C screening through 79, generally once, with repeat testing when exposure risk continues.

Recommendations against testing and gaps in evidence

The USPSTF’s recommendations against screening people without symptoms for ovarian, pancreatic and thyroid cancer, narrowing of the neck arteries and chronic obstructive pulmonary disease (COPD), which obstructs airflow, still apply, as covered in the 50s article. For hearing loss, the USPSTF found the evidence insufficient to recommend for or against screening older adults without symptoms. If you notice trouble hearing, that’s a reason to be tested, as covered in Does Hearing Loss Cause Dementia?

What distinguishes a recommendation against screening from an evidence gap about screening?

What does the Medicare wellness visit include?

Medicare covers a yearly wellness visit that includes a written prevention plan and an assessment of memory and thinking. Medicare.gov says the first visit cannot fall within 12 months of Part B enrollment or the separate Welcome to Medicare preventive visit. The wellness visit is a planning conversation, not a comprehensive physical exam. It costs nothing when the provider accepts Medicare’s approved payment amount; additional services may create charges. How to use it is covered in Longevity Checklist for Your 60s.

What’s Interesting

The colorectal recommendation shows why an age cutoff is not always a stop sign. The USPSTF recommends routine screening through 75 but selective screening from 76 to 85 because prior screening, overall health and the time available to benefit change the balance. The potential harms—false positives, colonoscopy complications and treatment of findings that may never cause illness—also remain part of that decision.

What This Means in Practice

For living longer and better in your 60s, the age-65 screening changes are worth reviewing with a clinician.

  • Review bone-density screening with a clinician: the USPSTF recommends it for women 65 and older and younger postmenopausal women at increased risk; prior fractures or secondary osteoporosis call for a different evaluation.
  • Discuss aortic-screening eligibility: the USPSTF recommends a one-time ultrasound from 65 to 75 for ever-smokers who meet its sex-at-birth category; a clinician can weigh the guideline and individual history.
  • Cervical screening after 65: the USPSTF’s stopping rule requires adequate prior screening and no high-risk condition; a clinician can check records before a change is made.
  • Fall prevention: the USPSTF recommends exercise interventions for adults 65 and older who live in the community and have increased fall risk; a fall or unsteadiness can prompt a risk discussion.
  • Continuing screening: colorectal, breast and eligible lung screening follow different intervals and stopping criteria that a clinician can review against personal history.
  • Medicare planning: the covered wellness visit includes a written prevention plan once its timing and eligibility rules are met.

A primary care clinician can tailor this list to your history and help you decide on tests with individual choices, such as PSA.

Bottom Line

At 65, women enter the USPSTF’s osteoporosis-screening group, and eligible ever-smokers enter its one-time aortic-ultrasound window, which uses sex-at-birth categories. People at increased fall risk qualify for an exercise intervention. Cervical screening can stop only with adequate prior screening and no high-risk condition; HIV testing continues after 65 when risk remains, while routine anxiety-screening evidence becomes insufficient rather than negative. Colorectal, breast and eligible lung screening continue on separate schedules. Their effects on disease-specific outcomes should not be confused with proof of longer overall life. A clinician can review the plan and prior screening records during a Medicare wellness visit.

A NOTE FROM LONGEVITY365

We read research, consult expert perspectives and work to make complicated health information easier to understand. What you’re reading here reflects how we’ve interpreted and organized that information. It is educational content—not personal medical advice, diagnosis or treatment guidance.

We’re not perfect, and neither is the available research. Evidence changes, new studies emerge and what’s appropriate for one person may not be appropriate for another.

Use this article as a starting point for your own research and conversations with qualified professionals. Always talk with your doctor or another trusted healthcare professional before making decisions that could affect your health, particularly if you take medications, are receiving treatment, have existing health conditions, are pregnant or have other circumstances that could affect what’s appropriate for you.

Reader Questions

A few questions to carry into the comments or your next conversation. Please leave out identifying or personal medical details.

  • 01Which part of this guide feels easiest to turn into a better question for a routine visit?
  • 02Where do you still feel the line is blurry between a useful check and more testing than you need?
  • 03What would make the next conversation clearer: timing, eligibility, possible harms, or what happens after an abnormal result?

Leave a Reply

Your email address will not be published. Required fields are marked *


Extra Insights & Sources

The evidence summaries and linked sources behind this article.

What We Know

  • The USPSTF recommends bone-density screening for women 65 and older and one-time aortic screening for eligible ever-smokers 65 to 75 under its sex-at-birth categories. Established.
  • The USPSTF advises stopping cervical screening after 65 only with adequate prior screening and no high-risk condition. Established guideline recommendation.
  • The USPSTF recommends exercise to prevent falls from 65 for adults living in the community who are at increased risk.
  • Colorectal, breast and eligible lung screening continue through their age limits. Established.

What We Don’t Know

  • Whether most screening tests extend overall lifespan. Uncertain; trials show fewer deaths from specific diseases more clearly than longer lives.
  • The value of screening older adults for anxiety or hearing loss. Uncertain (USPSTF I statements).
  • How pending USPSTF updates will change the list. Uncertain.

Sources

  • USPSTF, Osteoporosis to Prevent Fractures: Screening (2025): supports screening women at 65, risk-based screening in younger postmenopausal women and insufficient evidence for men; the recommendation excludes prior fragility fracture and secondary osteoporosis.
  • USPSTF, Abdominal Aortic Aneurysm: Screening (2019): supports one-time ultrasound for ever-smokers 65–75 in its “men” category, with benefits estimated by sex at birth rather than gender identity; selective screening for never-smokers in that category, the D grade for never-smokers without family history in its “women” category and the I statement for higher-risk people in that category.
  • USPSTF, Falls Prevention in Community-Dwelling Older Adults (2024): supports exercise for adults 65+ at increased risk; it is an intervention recommendation, not a mandate for one universal fall-risk screening instrument.
  • USPSTF, Cervical Cancer: Screening (2018 current final): supports stopping after 65 only with adequate prior screening and no high-risk condition; an update is underway.
  • USPSTF, Anxiety Disorders in Adults: Screening (2023): supports screening adults younger than 65 and the insufficient-evidence finding at 65+; the latter is not a recommendation against evaluating symptoms.
  • USPSTF, HIV Screening (2019): supports routine screening at 15–65 and screening outside that range when risk is increased; repeat intervals are risk-based.
  • USPSTF, Prostate Cancer Screening (2018 current final): supports individual decision-making at 55–69 and no routine screening from 70; an update is in progress.
  • USPSTF, Prediabetes and Type 2 Diabetes Screening (2021), and ADA, Standards of Care in Diabetes—2026: support the different age and risk populations stated; the ADA does not share the USPSTF’s age-70 upper boundary.
  • USPSTF, Colorectal, Breast and Lung Cancer screening recommendations: support the continuing ages, intervals and lung-screening stopping criteria stated; each applies only to its defined population.
  • USPSTF, Statin Use for Primary Prevention (2022), and ACC/AHA, 2026 Dyslipidemia Guideline Summary: support the distinction between the USPSTF age-40–75 statin recommendation and the newer PREVENT-based professional guideline.
  • USPSTF, Depression and Suicide Risk in Adults (2023), and Hepatitis C Screening (2020): support continued depression screening and HCV screening through 79, with repeat HCV testing for continuing risk.
  • USPSTF recommendations on ovarian, pancreatic, thyroid, carotid-artery and COPD screening: support the D-grade list for asymptomatic average-risk adults; symptoms and high-risk syndromes require diagnostic or specialized pathways.
  • USPSTF, Hearing Loss in Older Adults: Screening (2021): supports insufficient evidence for routine screening in asymptomatic adults 50+; reported hearing problems still warrant assessment.
  • Bretthauer et al., Estimated Lifetime Gained With Cancer Screening Tests (JAMA Internal Medicine, 2023; meta-analysis of randomized trials, 2,111,958 participants): supports separating disease-specific mortality benefit from evidence for overall-lifetime gain; heterogeneous tests and median follow-up of 10–15 years limit broad conclusions.
  • CMS, Annual Wellness Visit, and Medicare.gov coverage page: support the written screening schedule, cognitive assessment and no-cost visit when assignment rules are met. The first yearly visit cannot fall within 12 months of Part B enrollment or the Welcome to Medicare preventive visit; additional tests or services can create costs, and the visit is not a comprehensive physical exam.

Photo credits

Images from Pexels.

Featured image: Image by wirestock via Envato Elements.

COMING INTO VIEW

Find your people.

The Humanic Blue Directory will help you discover and filter service providers in your area.

This is a preview of what’s to come. The directory isn’t available yet.

Excerpt from the existing editorial library. Local design preview.